CTOs on the Move


 
Radeas is a clinical laboratory that offers testing for toxicology, COVID-19, PGX, UTI, and blood. They provide timely and accurate information to help guide decisions and ensure improved outcomes, with excellent customer service and a broad network of...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.radeas.com
  • 907, Gateway Commons Circle
    Wake Forest, NC USA 27587
  • Phone: 919.263.1150

Executives

Name Title Contact Details

Similar Companies

Sunrise Dental Lab

Sunrise Dental Lab is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MediBuddy

MediBuddy is one of the best (cashless) healthcare providers in India. At MediBuddy you can book Health check packages, online lab tests, online medicines, online doctor consultation, teleconsultation, dental consultation and many more. You can also bo...

AcelRx

AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company`s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and ZALVISO®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. In clinical studies, DSUVIA demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and vomiting. A New Drug Application (NDA) was filed with the FDA in December 2016. ZALVISO is designed to deliver sublingual tablets containing 15 mcg sufentanil via a novel hand-held, pre-programmed, patient-controlled analgesia system. Three Phase 3 clinical trials have been completed in patients who had undergone major abdominal or orthopedic surgeries. A fourth study (IAP312) is underway to further evaluate the overall performance of the ZALVISO System in post-surgical patients. ZALVISO is currently approved by the European Commission for the management of acute moderate-to-severe post-operative pain in adult patients in a hospital setting, and is marketed by Grünenthal Group, AcelRx`s licensee in Europe and Australia. In the United States and other geographies, ZALVISO remains an investigational product.

Health Access Washoe County

Health Access Washoe County is a Reno, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Unlock Health

Unlock Health Chiropractic is a natural medical service provider that offers long term solutions and overall wellness for families.